Skip to main content

Advertisement

SpringerLink
Log in

Stellungnahme zur Präparatewahl bei TNF-Inhibitoren

  • BEITRAG ZUM SCHWERPUNKTTHEMA
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Manger B (2002) Überarbeitete Empfehlungen der Deutschen Gesellschaft für Rheumatologie mit Tumornekrosefaktor-hemmenden Wirkstoffen bei entzündlich rheumatischen Erkrankungen. Z Rheumatol 61:694–697

    Google Scholar 

  2. Furst DE et al (2004) Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin receptor antagonist (IL-1ra), for the treatment of rheumatic diseases. Ann Rheum Dis 63 (Suppl. II):ii2-ii12

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik III, Universität Erlangen, Krankenhausstraße 12, 91054, Erlangen

    B. Manger

Authors
  1. B. Manger
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

und die Kommission Pharmakotherapie der DGRh

Rights and permissions

Reprints and permissions

About this article

Cite this article

Manger, B. Stellungnahme zur Präparatewahl bei TNF-Inhibitoren. Z. Rheumatol. 64, 88–89 (2005). https://doi.org/10.1007/s00393-005-0708-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-005-0708-6

Search

Navigation